TRLV Trulieve Cannabis Corp.
Trulieve Cannabis (TRLV) news
Trulieve Cannabis Corp. is a public biotech or pharmaceutical company listed on NYSE under the ticker TRLV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Trulieve Cannabis news
We have not published a story on Trulieve Cannabis yet. When there is news, it will appear here.
Trulieve Cannabis annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.18 billion | $1.19 billion |
| Cash from operations | $272.8 million | $271.5 million |
| Cash and equivalents | $255.5 million | $238.8 million |
| Short-term investments | $0 | $60.4 million |
Questions about Trulieve Cannabis
What is the ticker symbol of Trulieve Cannabis?
Trulieve Cannabis Corp. trades under the ticker TRLV on NYSE.
Where is Trulieve Cannabis listed?
Trulieve Cannabis Corp. is listed on NYSE.
Which country or territory is Trulieve Cannabis listed under?
Our directory records Trulieve Cannabis Corp. under United States.
Does aibio.space cover Trulieve Cannabis?
aibio.space lists Trulieve Cannabis Corp. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Trulieve Cannabis's revenue last year?
$1.18 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.
How much cash does Trulieve Cannabis have?
$325.4 million in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: Trulieve Cannabis
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 1.01,3.02,3.03,5.03,9.01). Source
- Mergers
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,7.01,9.01). Source
- Financings
Announced a share repurchase program. SEC Form 8-K (Items 8.01,9.01). Source
- Mergers
Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,9.01). Source
Stock chart
Listing details
- Company
- Trulieve Cannabis Corp.
- Ticker
- TRLV
- Listing
- NYSE
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio